Virtual Conference

Track: Transplantation: Heart and Lungs

Heart 2023 Conference - Heart and Lung Transplantation

Sub-Track:

The market for heart transplants was valued at USD 9,926.86 million in 2021, and it is anticipated to grow significantly over the forecast period of 2022–2030, by 10.10%, to reach USD 15,813.98 million. During the forecast period, the worldwide heart transplant market is expected to expand at a noteworthy CAGR of 10.3%. The increasing incidence of heart failure fuels the need for effective treatment strategies, which in turn fuels market expansion.

Advanced Heart Failure and Transplantation (HEART)

·        HEART–Access to Care/Caregiver
·        HEART–Basic Science-Immunology, Inflammation
·        HEART–Basic Science-Models of Organ Preservation, Perfusion and Graft Injury
·        HEART–Basic Science-Translational Research/Other
·        HEART–Basic Science-Xenotransplantation/Regenerative Medicine/Artificial Organs
·        HEART–Cardiac Allograft Vasculopathy
·        HEART–Cardiogenic Shock
·        HEART–Clinical Ex-Vivo Perfusion and Preservation
·        HEART–Compliance/Adherence/Psychosocial Aspects
·        HEART–Complications Other
·        HEART–Congenital Heart Disease Management
·        HEART–COVID-19 Vaccine Pre- and Post-Transplant
·        HEART–COVID-19 Non-Vaccine related
·        HEART–Critical Care Medicine/Peri-operative/Intra-operative Management
·        HEART–Diagnostics/Patient Management/Patient Care Pathways
·        HEART–Donor Management
·        HEART–Economics, Ethics, Public Policy/Health Equity
·        HEART–Immunology, Inflammation (Clinical)
·        HEART–Infectious Diseases - Diagnostics and Complications
·        HEART–Infectious Diseases - Management and Therapeutics
·        HEART–Organ Allocation
·        HEART–Other (Clinical)
·        HEART–Outcomes (Effectiveness)
·        HEART–Outcomes (Other)
·        HEART–Outcomes (Risk Prediction/Modelling)
·        HEART–Outcomes (Safety)
·        HEART–Palliative Care/Self Care/Symptom Management
·        HEART–Pathology
·        HEART–Patient Selection for Advanced Therapies/Rehabilitation
·        HEART–Pediatrics-Basic and Translational Research
·        HEART–Pediatrics-Complications
·        HEART–Pediatrics-Heart Failure
·        HEART–Pediatrics-Other
·        HEART–Pediatrics-Outcomes
·        HEART–Pediatrics-Patient Selection, Organ Allocation, Donor Management
·        HEART–Pharmacology, Therapeutics, Immunosuppression
·        HEART–Primary Graft Dysfunction
·        HEART–Quality of Life/Quality Improvement
·        HEART–Rejection-Antibody Mediated (AMR)
·        HEART–Rejection-Cellular
·        HEART–Telehealth/Remote Monitoring and Interventions
 
Advanced Lung Failure and Transplantation (LUNG)

·        LUNG–Basic Science-Immunology, Inflammation
·        LUNG–Basic Science-Organ Preservation, Perfusion and Graft Injury
·        LUNG–Basic Science-Translational Research/Other
·        LUNG–Basic Science-Xenotransplantation/Regenerative Medicine/Artificial Organs
·        LUNG–Caregiver and Psychosocial Aspects/Adherence to Care
·        LUNG–Chronic Lung Allograft Dysfunction (CLAD)
·        LUNG–Clinical Ex-Vivo Perfusion and Preservation
·        LUNG–COVID-19
·        LUNG–Critical Care Medicine/Peri-operative Care
·        LUNG–Diagnostics and Pathology
·        LUNG–Donor Management and Organ Allocation
·        LUNG–ECLS/Short-Term Support
·        LUNG–Economics, Ethics, Public Policy
·        LUNG–Immunology, Inflammation (Clinical)
·        LUNG–Infectious Diseases
·        LUNG–Other/Complications (Clinical)
·        LUNG–Palliative Care/Symptom Management
·        LUNG–Pediatrics
·        LUNG–Pharmacology, Therapeutics, Immunosuppression
·        LUNG–Primary Graft Dysfunction
·        LUNG–Quality Improvement/Service Development/Access to Care
·        LUNG–Quality of Life/Frailty/Patient Reported Outcomes
·        LUNG–Recipient Selection for Transplant and/or Advanced Therapies
·        LUNG–Rejection (Acute)
·        LUNG–Surgical Aspects of Lung Transplantation
·        LUNG–Survival/Prognostication 



Related Hospitals: Cleveland ClinicMayo Clinic, New York-Presbyterian Hospital, Cedars-Sinai Medical CenterMassachusetts General Hospital, NewYork-Presbyterian Hospital-Columbia and Cornell, Johns Hopkins HospitalNYU Langone Hospitals, Northwestern Memorial Hospital, Hospitals of the University of Pennsylvania-Penn Presbyterian, Mount Sinai HospitalUniversity of Michigan Hospitals and Health Centers, Duke University HospitalBrigham and Women's Hospital, Barnes-Jewish Hospital, UCLA Medical Center, Stanford Health Care-Stanford Hospital, Heart Hospital Baylor Plano, Houston Methodist Hospital, Loyola University Medical Center, NYU Langone Medical Center, UPMC Presbyterian Shadyside, Scripps La Jolla Hospitals, Ohio State University Wexner Medical Center, UCSF Medical Center, Sentara Norfolk General Hospital-Sentara Heart Hospital, Texas Heart Institute at Baylor St. Luke's Medical Center, Beaumont Hospital-Royal Oak, Minneapolis Heart Institute at Abbott Northwestern Hospital, Vanderbilt University Medical Center, Memorial Hermann-Texas Medical Center, The University of Alabama at Birmingham Hospital, University of Colorado HospitalSt. Francis Hospital.